Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.
about
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsTranscription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneA meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinomaAssociation of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.Telomere Maintenance Mechanisms in Cancer.Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates
P2860
Q26738705-0EF873BB-4E44-4A7E-88FA-D2A960526AE4Q26739925-437F25CB-CE8C-46FF-B538-58E5FCAA40DBQ33656624-1F99337E-BE30-42D2-BA4B-2E4861BBA71AQ36221232-B9F41DD8-6069-4C1E-A341-60D493E0CCD8Q38886234-43503BAE-F91B-4F91-BA09-59C2D35D7F25Q47646209-C7215808-DA06-4DC7-9A07-8ACE16B1E99AQ47991246-83702735-8CCE-4D8A-BE1A-472A1E7D1853Q55443450-3653C36C-247D-4CE5-9111-B82C56669BF5Q58796314-4201F001-E10E-4CDA-AA53-307AAB833C3B
P2860
Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical utility of TERT promo ...... ce of the BRAF V600E mutation.
@ast
Clinical utility of TERT promo ...... ce of the BRAF V600E mutation.
@en
type
label
Clinical utility of TERT promo ...... ce of the BRAF V600E mutation.
@ast
Clinical utility of TERT promo ...... ce of the BRAF V600E mutation.
@en
prefLabel
Clinical utility of TERT promo ...... ce of the BRAF V600E mutation.
@ast
Clinical utility of TERT promo ...... ce of the BRAF V600E mutation.
@en
P2093
P2860
P1433
P1476
Clinical utility of TERT promo ...... ce of the BRAF V600E mutation.
@en
P2093
Dong Jun Lim
Ja Seong Bae
Min-Hee Kim
Se Hee Kim
Tae Jung Kim
Youn Soo Lee
Yourha Kim
P2860
P2888
P356
10.1186/S13000-016-0458-6
P577
2016-02-09T00:00:00Z
P5875
P6179
1034862698